ADHD medications are often portrayed as dangerous, addictive, or bad for your heart, but the research tells a very different story. This article unpacks common myths about stimulants and shows how, when used correctly, they can lower risks like accidents, substance use, and early death while improving everyday life for neurodivergent people.

Mast Cell Activation Syndrome (MCAS) may contribute to neurodivergent experiences by driving neuroinflammation that affects sensory processing, mood, and cognition, yet it does not define or explain all neurodiversity. This article explores emerging research on MCAS in autism, ADHD, and related conditions while emphasizing neurodiversity-affirming, trauma-informed care and the need for cautious, individualized, evidence-based approaches to mast-cell‑targeted treatment.

Bipolar disorder is more than “highs and lows”—it is a chronic, episodic mood condition that exists on a spectrum and often overlaps with ADHD, anxiety, autism, and other diagnoses. With accurate assessment, mood‑stabilizing treatments, psychotherapy, and lifestyle supports, many people achieve stability, reduce suicide risk, and build meaningful, self-directed lives.